| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AKAP10
|
A kinase (PRKA) anchor protein 10
|
|
ALB
|
albumin
|
|
ANOS1
|
anosmin 1
|
|
APC
|
adenomatous polyposis coli
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AURKA
|
aurora kinase A
|
|
BCHE
|
butyrylcholinesterase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CFHR1
|
complement factor H-related 1
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRM4
|
cholinergic receptor, muscarinic 4
|
|
CREBBP
|
CREB binding protein
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DAO
|
D-amino-acid oxidase
|
|
DMD
|
dystrophin
|
|
EDN3
|
endothelin 3
|
|
EFNB2
|
ephrin-B2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
ENO1
|
enolase 1, (alpha)
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
F10
|
coagulation factor X
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOXO1
|
forkhead box O1
|
|
GART
|
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLDC
|
glycine dehydrogenase (decarboxylating)
|
|
GNAS
|
GNAS complex locus
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HIRA
|
histone cell cycle regulator
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD3B1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB6
|
integrin, beta 6
|
|
ITGB7
|
integrin, beta 7
|
|
JAK2
|
Janus kinase 2
|
|
KDR
|
kinase insert domain receptor
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LEP
|
leptin
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
|
LMX1B
|
LIM homeobox transcription factor 1, beta
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NF1
|
neurofibromin 1
|
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD10
|
programmed cell death 10
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PFKP
|
phosphofructokinase, platelet
|
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PMCH
|
pro-melanin-concentrating hormone
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POLI
|
polymerase (DNA directed) iota
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCG
|
protein kinase C, gamma
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
RB1
|
retinoblastoma 1
|
|
RET
|
ret proto-oncogene
|
|
RGS16
|
regulator of G-protein signaling 16
|
|
RGSL1
|
regulator of G-protein signaling like 1
|
|
SELL
|
selectin L
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SELPLG
|
selectin P ligand
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SHOX
|
short stature homeobox
|
|
SLC10A2
|
solute carrier family 10 (sodium/bile acid cotransporter), member 2
|
|
SLC47A1
|
solute carrier family 47 (multidrug and toxin extrusion), member 1
|
|
SLC47A2
|
solute carrier family 47 (multidrug and toxin extrusion), member 2
|
|
SLCO1A2
|
solute carrier organic anion transporter family, member 1A2
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLCO2B1
|
solute carrier organic anion transporter family, member 2B1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
STIM1
|
stromal interaction molecule 1
|
|
TBX1
|
T-box 1
|
|
TGM2
|
transglutaminase 2
|
|
TLR7
|
toll-like receptor 7
|
|
TP53
|
tumor protein p53
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
|
VWF
|
von Willebrand factor
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
